Matthew Reynolds to Risk
This is a "connection" page, showing publications Matthew Reynolds has written about Risk.
Connection Strength
0.263
-
Cannon CP, Khan I, Klimchak AC, Sanchez RJ, Sasiela WJ, Massaro JM, D'Agostino RB, Reynolds MR. Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease. Am Heart J. 2019 10; 216:30-41.
Score: 0.146
-
Reynolds MR, Josephson ME. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation. 2003 Oct 14; 108(15):1779-83.
Score: 0.049
-
Carbuhn AF, Sanchez Z, Fry AC, Reynolds MR, Magee LM. A Simplified Prediction Model for Lower Extremity Long Bone Stress Injuries in Male Endurance Running Athletes. Clin J Sport Med. 2020 09; 30(5):e124-e126.
Score: 0.040
-
Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323.
Score: 0.027